Revised edition of: Kumar & Clark's clinical medicine / edited by Parveen Kumar, Michael Clark. 8th ed. 2012.

Includes bibliographical references.

Ethics, law and communication -- Clinical pharmacology -- Palliative medicine and symptom control -- Global health -- Environmental medicine -- Poisoning -- Molecular cell biology and human genetics -- The immune system and disease -- Water, electrolytes and acid-base balance -- Nutrition -- Infectious diseases and tropical medicine -- Sexually transmitted infections and human immunodeficiency virus -- Gastrointestinal disease -- Liver disease -- Biliary tract and pancreatic disease -- Haematological disease -- Malignant disease -- Rheumatic disease -- Bone disease -- Kidney and urinary tract disease -- Neurological disease -- Psychological medicine -- Cardiovascular disease -- Respiratory disease -- Critical care medicine -- Endocrine disease -- Diabetes mellitus -- Lipid and metabolic disorders -- Women's health -- Ear, nose and throat and eye disease -- Skin disease.

Access restricted to authorized users and institutions.

The ninth edition of this best-selling textbook of clinical medicine builds even further on its formidable, prize-winning formula of excellence, comprehensiveness and accessibility. 'This book is stunning in its breadth and ease-of-use. It still remains the "gold standard", thorough guide to clinical medicine its forefathers were.' BMA Medical Book Awards judges. New to this edition: 2 new chapters: Global Health and Women's Health. 25 new authors. New online editor, Adam Feather, with a team of young doctors to augment the e-book which accompanies the print book with clinical tips, key learning points, drug tips, learning challenges, case studies and MCQs. Full text redesign to incorporate: New system overview diagrams for clinical chapters. New coloured headings to help identify content relating to disease, management, investigations etc. New icons to aid text navigation. 11 new members and a new co-editor, Senaka Rajapakse, of the International Advisory Board.